Showing results (6991-7000 of 45,234) with videos related to
Sort By:
Pageof 4,524
Cancer Research|July 20, 2006
Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skinHong Guo, Hui Miao, Lizabeth Gerber, et al.Cancer Research|July 20, 2006
Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinomaMichael A Kern, Anke M Haugg, Andreas F Koch, et al.Cancer Research|July 20, 2006
Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanismsYuan Rong, Fang Hu, Ruopan Huang, et al.Cancer Research|July 20, 2006
Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient miceMarkus J V Vähä-Koskela, Janne P Kallio, Linda C Jansson, et al.Cancer Research|July 20, 2006
Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agentsKlaus Mantwill, Nadia Köhler-Vargas, Alexandra Bernshausen, et al.Cancer Research|July 20, 2006
In vivo tumor targeting using a novel intestinal pathogen-based delivery approachKlaus-Peter Janssen, Danijela Vignjevic, Raphaël Boisgard, et al.Cancer Research|July 20, 2006
E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agentsAngelo J Russo, Pellegrino G Magro, Zhen Hu, et al.Cancer Research|July 20, 2006
Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical modelAntonio Cappuccio, Moran Elishmereni, Zvia AgurCancer Research|July 20, 2006
Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar originsJack D Bui, Ravindra Uppaluri, Chyi-Song Hsieh, et al.Cancer Research|July 20, 2006
Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicityAndreas Lundqvist, Scott I Abrams, David S Schrump, et al.Pageof 4,524